Medical Devices & Consumables

Global Continuous Subcutaneous Insulin Infusion Therapy Market Insights, Forecast to 2030

An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
Market Analysis and Insights: Global Continuous Subcutaneous Insulin Infusion Therapy Market
The global Continuous Subcutaneous Insulin Infusion Therapy market is projected to grow from US$ 752 million in 2024 to US$ 1210 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Continuous Subcutaneous Insulin Infusion Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Continuous Subcutaneous Insulin Infusion Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Continuous Subcutaneous Insulin Infusion Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Continuous Subcutaneous Insulin Infusion Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Continuous Subcutaneous Insulin Infusion Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Continuous Subcutaneous Insulin Infusion Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport
Segment by Type
Normal
Patch Pump
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Continuous Subcutaneous Insulin Infusion Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Continuous Subcutaneous Insulin Infusion Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Continuous Subcutaneous Insulin Infusion Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Normal
1.2.3 Patch Pump
1.3 Market by Application
1.3.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Perspective (2019-2030)
2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Growth Trends by Region
2.2.1 Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Continuous Subcutaneous Insulin Infusion Therapy Historic Market Size by Region (2019-2024)
2.2.3 Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Region (2025-2030)
2.3 Continuous Subcutaneous Insulin Infusion Therapy Market Dynamics
2.3.1 Continuous Subcutaneous Insulin Infusion Therapy Industry Trends
2.3.2 Continuous Subcutaneous Insulin Infusion Therapy Market Drivers
2.3.3 Continuous Subcutaneous Insulin Infusion Therapy Market Challenges
2.3.4 Continuous Subcutaneous Insulin Infusion Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Continuous Subcutaneous Insulin Infusion Therapy by Players
3.1.1 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue by Players (2019-2024)
3.1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Continuous Subcutaneous Insulin Infusion Therapy Market Concentration Ratio
3.4.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Subcutaneous Insulin Infusion Therapy Revenue in 2023
3.5 Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy Head office and Area Served
3.6 Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy, Product and Application
3.7 Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Subcutaneous Insulin Infusion Therapy Breakdown Data by Type
4.1 Global Continuous Subcutaneous Insulin Infusion Therapy Historic Market Size by Type (2019-2024)
4.2 Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Type (2025-2030)
5 Continuous Subcutaneous Insulin Infusion Therapy Breakdown Data by Application
5.1 Global Continuous Subcutaneous Insulin Infusion Therapy Historic Market Size by Application (2019-2024)
5.2 Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
6.2 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type
6.2.1 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024)
6.2.2 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030)
6.2.3 North America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
6.3 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application
6.3.1 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024)
6.3.2 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030)
6.3.3 North America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
6.4 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country
6.4.1 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
6.4.3 North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
7.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type
7.2.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024)
7.2.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030)
7.2.3 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
7.3 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application
7.3.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024)
7.3.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030)
7.3.3 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
7.4 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country
7.4.1 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
7.4.3 Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
8.2 China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type
8.2.1 China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024)
8.2.2 China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030)
8.2.3 China Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
8.3 China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application
8.3.1 China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024)
8.3.2 China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030)
8.3.3 China Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
9.2 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type
9.2.1 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024)
9.2.2 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030)
9.2.3 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
9.3 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application
9.3.1 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024)
9.3.2 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030)
9.3.3 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
9.4 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region
9.4.1 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2019-2024)
9.4.3 Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.1.4 Medtronic Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.1.5 Medtronic Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.2.4 Roche Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.2.5 Roche Recent Developments
11.3 SOOIL
11.3.1 SOOIL Company Details
11.3.2 SOOIL Business Overview
11.3.3 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.3.4 SOOIL Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.3.5 SOOIL Recent Developments
11.4 Tandem Diabetes care
11.4.1 Tandem Diabetes care Company Details
11.4.2 Tandem Diabetes care Business Overview
11.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.4.4 Tandem Diabetes care Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.4.5 Tandem Diabetes care Recent Developments
11.5 Insulet Corp
11.5.1 Insulet Corp Company Details
11.5.2 Insulet Corp Business Overview
11.5.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.5.4 Insulet Corp Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.5.5 Insulet Corp Recent Developments
11.6 Valeritas
11.6.1 Valeritas Company Details
11.6.2 Valeritas Business Overview
11.6.3 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.6.4 Valeritas Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.6.5 Valeritas Recent Developments
11.7 Microport
11.7.1 Microport Company Details
11.7.2 Microport Business Overview
11.7.3 Microport Continuous Subcutaneous Insulin Infusion Therapy Introduction
11.7.4 Microport Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
11.7.5 Microport Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Normal
Table 3. Key Players of Patch Pump
Table 4. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Region (2019-2024)
Table 8. Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Region (2025-2030)
Table 10. Continuous Subcutaneous Insulin Infusion Therapy Market Trends
Table 11. Continuous Subcutaneous Insulin Infusion Therapy Market Drivers
Table 12. Continuous Subcutaneous Insulin Infusion Therapy Market Challenges
Table 13. Continuous Subcutaneous Insulin Infusion Therapy Market Restraints
Table 14. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Share by Players (2019-2024)
Table 16. Global Top Continuous Subcutaneous Insulin Infusion Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Therapy as of 2023)
Table 17. Global Continuous Subcutaneous Insulin Infusion Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Continuous Subcutaneous Insulin Infusion Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy, Headquarters and Area Served
Table 20. Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy, Product and Application
Table 21. Global Key Players of Continuous Subcutaneous Insulin Infusion Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Share by Application (2019-2024)
Table 29. Global Continuous Subcutaneous Insulin Infusion Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Share by Application (2025-2030)
Table 31. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Continuous Subcutaneous Insulin Infusion Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Continuous Subcutaneous Insulin Infusion Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Continuous Subcutaneous Insulin Infusion Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 63. Medtronic Company Details
Table 64. Medtronic Business Overview
Table 65. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Product
Table 66. Medtronic Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 67. Medtronic Recent Developments
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Continuous Subcutaneous Insulin Infusion Therapy Product
Table 71. Roche Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 72. Roche Recent Developments
Table 73. SOOIL Company Details
Table 74. SOOIL Business Overview
Table 75. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Product
Table 76. SOOIL Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 77. SOOIL Recent Developments
Table 78. Tandem Diabetes care Company Details
Table 79. Tandem Diabetes care Business Overview
Table 80. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Product
Table 81. Tandem Diabetes care Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 82. Tandem Diabetes care Recent Developments
Table 83. Insulet Corp Company Details
Table 84. Insulet Corp Business Overview
Table 85. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Product
Table 86. Insulet Corp Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 87. Insulet Corp Recent Developments
Table 88. Valeritas Company Details
Table 89. Valeritas Business Overview
Table 90. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Product
Table 91. Valeritas Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 92. Valeritas Recent Developments
Table 93. Microport Company Details
Table 94. Microport Business Overview
Table 95. Microport Continuous Subcutaneous Insulin Infusion Therapy Product
Table 96. Microport Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024) & (US$ Million)
Table 97. Microport Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type: 2023 VS 2030
Figure 3. Normal Features
Figure 4. Patch Pump Features
Figure 5. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Continuous Subcutaneous Insulin Infusion Therapy Report Years Considered
Figure 11. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global Continuous Subcutaneous Insulin Infusion Therapy Market Share by Players in 2023
Figure 15. Global Top Continuous Subcutaneous Insulin Infusion Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Continuous Subcutaneous Insulin Infusion Therapy Revenue in 2023
Figure 17. North America Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
Figure 19. North America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
Figure 20. North America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Country (2019-2030)
Figure 21. United States Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
Figure 25. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
Figure 26. Europe Continuous Subcutaneous Insulin Infusion Therapy Market Share by Country (2019-2030)
Figure 27. Germany Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
Figure 35. China Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
Figure 36. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
Figure 38. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
Figure 39. Asia Continuous Subcutaneous Insulin Infusion Therapy Market Share by Region (2019-2030)
Figure 40. Japan Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Continuous Subcutaneous Insulin Infusion Therapy Market Share by Country (2019-2030)
Figure 50. Brazil Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Continuous Subcutaneous Insulin Infusion Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Medtronic Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 57. Roche Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 58. SOOIL Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 59. Tandem Diabetes care Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 60. Insulet Corp Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 61. Valeritas Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 62. Microport Revenue Growth Rate in Continuous Subcutaneous Insulin Infusion Therapy Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies